NCT00842582View on ClinicalTrials.gov

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Ovarian Cancer
Interventions
DRUG

Azacitidine

Azacitidine 20 milligrams per meter squared subcutaneous once daily for 7 days.

DRUG

Azacitidine

Azacitidine 40 milligrams per meter squared subcutaneous once daily for 7 days.

DRUG

Azacitidine

Azacitidine 75 milligrams per meter squared subcutaneous once daily for 7 days.

Trial Locations (2)

60153

Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center, Maywood

60190

Central Dupage Hospital, Winfield

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Loyola University

OTHER